BACKGROUND: Cardiovascular death (CVD) is a leading cause of death and constitutes a major burden on society. Left ventricular mechanical dyssynchrony (LVMD), evaluated as SD of time to peak regional longitudinal strain, is a capable predictor of many cardiovascular outcomes related to CVD, including ventricular arrhythmias, but the prognostic utility of LVMD in the general population is unknown. Hence, this study sought to determine the prognostic value of LVMD in the general population in predicting CVD.
C
ardiovascular death (CVD) is the most common cause of death on a global level, and 31% of total deaths in 2015 were estimated to be of cardiovascular origin. 1 Furthermore, in 50% of all CVDs, the underlying cause is suspected to be sudden cardiac death (SCD) from ventricular fibrillation. 2 To complicate this further, many cases of SCD in the general population happen in individuals without prevalent cardiovascular disease. 2 Thus, because of the heterogeneous pathophysiology underlying CVD, identification of highrisk individuals in the general population remains challenging. Healthy cardiac function is intimately tied to the highly synchronous nature of the myocardial functional syncytium. This synchronicity is impaired in many cardiac pathologies, including coronary artery disease and malignant arrhythmias, such as ventricular fibrillation. 3 Therefore, it seems natural to investigate the prognostic value of a dyssynchronous cardiac function in predicting CVD.
Left ventricular (LV) mechanical dyssynchrony (LVMD; also known as LV mechanical dispersion) can be assessed from 2-dimensional speckle tracking (2DSTE) using the SD of time-to-peak regional longitudinal strain values. LVMD has been shown to correlate strongly to markers of atherosclerotic and ischemic disease, such as carotid intima-media thickness, carotid plaque score, and coronary calcium score in a low-risk general population free of cardiovascular disease (CVD). 4 Hence, LVMD may, therefore, be useful in identifying subclinical stages of ischemic heart disease in the general population, a pathology that severely predisposes an individual to SCD. SCD is thought to be predominantly caused by malignant ventricular arrhythmias, can be attributed to both ischemic and nonischemic pathogenesis, and can occur in seemingly healthy individuals, making risk stratification difficult. 5 LVMD has shown proficiency in predicting malignant ventricular arrhythmias in nonischemic dilated cardiomyopathy, Chagas cardiomyopathy, hypertrophic cardiomyopathy, systolic heart failure (HF), and following acute myocardial infarction (AMI). [6] [7] [8] [9] [10] [11] [12] This suggests that LVMD may be able to quantify risk of SCD, a major contributor to CVD.
In light of presented evidence, LVMD shows promise in detecting early cardiac dysfunction and subtle stages of CVD over a broad spectrum of underlying pathologies. Therefore, this study seeks to investigate the prognostic value of LVMD in predicting CVD in the general population.
METHODS
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure. Because this study uses data from human subjects, the data and everything pertaining to it is governed by the Danish Data Protection Agency and can only be made available to any additional researchers if a formal request is filed with the Danish Authorities.
Study Sample
The Copenhagen City Heart Study is a longitudinal cohort study designed to study cardiovascular disease and associated risk factors in the general population. The population has been previously described in detail. [13] [14] [15] [16] The population is based in and around the city of Copenhagen, Denmark. This substudy includes all participants in the fourth round of examination who had an echocardiogram including 2DSTE performed, conducted from 2001 to 2003. The decision to allocate a participant to echocardiographic examination during the fourth round of examination was random and thus independent of both health status and risk factors. Echocardiographic examination took place in the same facilities as all other parts of the fourth round of examinations. The echocardiograms were performed by experienced sonographers blinded to all personal or clinical information about the patient. Patients were randomly invited for echocardiograms from the waiting area of the facilities by the sonographers, and no other information but a unique anonymized examination number was recorded by the sonographer during the examination. A total of 2221 participants underwent an echocardiogram with tissue Doppler imaging and the potential for offline 2DSTE analysis. 16 The study population has previously been described in detail. 16 In the present report, 78 participants were excluded because of atrial fibrillation or significant valvular disease. Then, 854 participants were excluded because of either inadequate frame rate for 2DSTE or inadequate image quality.
CLINICAL PERSPECTIVE
Left ventricular mechanical dyssynchrony (LVMD) reflects the degree of left ventricular contractile dyssynchrony and has demonstrated prognostic value in heart failure and other cardiovascular diseases. LVMD has also been shown to predict ventricular arrhythmias in heart failure and following acute myocardial infarction and has been a target of interest in cardiac resynchronization therapy. However, no studies have evaluated the prognostic value of LVMD in predicting cardiovascular death in the general population. Risk stratification of individuals in the general population with respect to cardiovascular death, particular with respect to sudden cardiac death, is challenging. Our results indicate that LVMD assessed by echocardiography may be useful in this process. Furthermore, we hypothesize that LVMD may be a potent predictor of sudden cardiac death in the general population. Future studies should focus on clarifying whether LVMD assessed by speckle tracking echocardiography is a potent predictor of sudden cardiac death in the general population as hypothesized in this study. Our results could lead to better identification of high-risk individuals in the general population and thus allow for earlier intervention.
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Finally, to ensure adequate multivariable adjustment of statistical models, 151 participants were excluded because of either missing clinical information or missing LV or left atrial chamber dimensions. This left 1138 participants for inclusion into this study. A comparison between excluded participants and participants included into the study is available in the Data Supplement (Table I in the Data Supplement) .
Ethics
Written consent was given by all participants, and the study complies with the second declaration of Helsinki. The study design was approved by a regional ethics committee.
General Health Examination
All participants underwent a general health examination. This consisted of a questionnaire and a physical examination. Blood pressure (BP) measurements were taken with a London School of Hygiene sphygmomanometer. Both plasma cholesterol levels and plasma glucose levels were collecting using nonfasting venous blood samples. 17 Plasma pro-B-type natriuretic peptide (pro-BNP) was measured using a processing-independent assay, and abnormal values defined as pro-BNP >150 pmol/L. Diabetes mellitus was defined as either a plasma glucose level >11.1 mmol/L, the use of glucose-lowering medications, selfreported disease, or a hemoglobin A1C >7.0%. Prevalent ischemic heart disease was defined as a history of admission for acute coronary artery occlusion, percutaneous coronary intervention, coronary artery bypass grafting, or major ECG alterations according to Minnesota codes 1.1 to 3.
Echocardiography
Echocardiograms were obtained by 3 experienced sonographers using Vivid 5 Ultrasound machines (GE Healthcare, Horten, Norway) and a 2.5-MHz transducer. All participants underwent conventional 2-dimensional imaging and color tissue Doppler imaging. The echocardiograms were stored on magneto-optical disks and on an external FireWire hard drive (LaCie, France). They underwent offline analysis by experienced investigators blinded to all outcomes and clinical data using commercially available software (EchoPac version 8, GE Healthcare, Horten, Norway).
Conventional Echocardiography
Wall motion score index was assessed using the 16-segment model as recommended by the American Society of Echocardiography. 18 LV ejection fraction (LVEF) was estimated from the wall motion score indexing. 14, 19 Reduced systolic function was defined as LVEF <50%. 18 LV hypertrophy was defined as a LV mass index (LVMI) ≥96 g/m 2 for women and an LVMI ≥116 g/m 2 for men. 18 LV dilation was defined as a LV internal diameter at end diastole indexed by height (LV internal diameter at end diastole/height) ≥3.3 cm/m. 18 LVMI was derived by indexing the anatomic mass with body surface area. 18 Mitral inflow patterns were measured using pulsed wave Doppler in the apical position between the mitral leaflet tips. Peak early (E) and late (A) diastolic inflow velocity was measured, and E/A ratio was calculated. Deceleration time of the E-wave was measured.
Color Tissue Doppler Imaging
Color tissue Doppler imaging velocity tracings with the range gate placed in the septal and lateral mitral annular position from the 4-chamber view were obtained, and peak longitudinal early diastolic velocity (e′) was determined. The average of the septal and lateral e′ value was calculated and used to derive the E/e′ value. Aortic valve timings were determined using a 2-to 4-cm straight M-mode line in the septal half of the mitral leaflet in the Color tissue Doppler imaging 4-chamber view.
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Speckle Tracking Echocardiography
2DSTE was performed in the apical 4-chamber, the apical 3-chamber, and the apical 2-chamber view. Mean frame rate was 57 frames per second (SD: 4 frames per second). The region of interest was defined through a semiautomated process, in which the investigator placed 2 markers by point and click at the endocardial-blood border at the level of the mitral annular plane, one in each side. An additional marker was placed in the endocardial border of the LV apex. The software then automatically detected the endocardial-blood border along the entire ventricular wall and divided the LV wall into 6 segments. If the endocardial border was not detected properly by the software, manual correction by the investigator was performed by point and click. All 6 segments were assessed by the investigator for adequate tracking, and if tracking was inadequate, attempts to correct this were performed. If tracking still proved to be unsatisfactory after manual correction or if the tracking was obscured by a shadow or artefact, the segment was excluded from analysis. Regional segmental calculation of strain and time-to-peak strain was performed by the software. LVMD was calculated as the SD of the regional time-to-peak strain values from each segment from each view, resulting in a total of 18 segmental time-to-peak strain values from the entire LV for LVMD calculation. Global longitudinal strain (GLS) was calculated as the average of peak strain from the 3 views. If either 1 of the 3 views was missing from any one patient, LVMD and other strain parameters were calculated from the remaining available views. A total of 1002 participants had 4 chamber views adequate for strain analysis, 724 participants had 2 chamber views adequate for strain analysis, and 541 participants had 3 chamber views of sufficient quality for strain analysis. The presence of LV dyssynchrony was defined as the cutoff for the upper tertile of LVMD values. All strain analysis was conducted by a single investigator blinded to all clinical data and all outcomes. GLS and strain values were reported as absolute values.
Variability Analysis
The intra-and interobserver variability of LVMD was tested in 20 randomly selected patients, and the analysis was performed blinded to both clinical data and outcomes. Reproducibility was assessed using intra-and interclass correlation coefficients. 
Statistics
All statistical analysis was done using STATA 13.0 for Mac OS. Gaussian distributed variables were compared between 2 groups using Student t test. Proportions between ≥2 groups were compared by the χ 2 test. Variables not displaying Gaussian distribution were log-transformed and assessed for Gaussian distribution. Linear regression with tertiles of LVMD included as a categorical variable was used to examine differences in baseline variables between tertiles of LVMD. In this analysis, the first tertile served as reference. Competing risk regression 21 was used to test the prognostic value of LVMD in predicting both CVD and NCD. When predicting CVD, NCD was treated as a competing risk. When predicting NCD, CVD was treated as a competing risk. Cumulative incidence curves with the population stratified according to tertiles of LVMD was constructed using the cumulative incidence function, and univariable competing risk regression with tertiles of LVMD was performed. Multivariable models were constructed using established predictors of CVD. The maximum number of adjusting variables was limited by the number of events of CVD (n=62), and the minimum number of events per adjusting variable was set to 5.
22 Model 1 is adjusted for age, sex, hypertension, systolic BP, diabetes mellitus, and smoking status. Model 2 is adjusted for the same variables as model 1 with the addition of previous myocardial infarction, previous ischemic stroke, prevalent HF, plasma pro-BNP levels, LVEF <50%, left atrium dimension, and GLS. Interaction analysis was used to test for statistically significant interaction between LVMD and other parameters; however, none reached significance. Reclassification analysis was used to assess the continuous net reclassification improvement 23 when adding LVMD and other parameters to the clinical predictors included in the Systemic Coronary Evaluation (SCORE) risk chart 24 and a modified version of the American College of Cardiology/American Heart Association Pooled Cohort equation. 25 A sensitivity analysis assessing the prognostic value of LVMD by competing risk regression with exclusion of participants with left bundle branch block or right bundle branch block was conducted to determine whether right bundle branch block or left bundle branch block affected our results. Statistical significance was defined as a P≤0.05 in 2 sided tests. Finally, we conducted a sensitivity analysis to determine whether missing LV segments because of not all apical views being available in all participants affected our results. This sensitivity analysis consisted of assessing the prognostic value of LVMD in models 1 and 2 with concomitant adjustment for the number of missing LV segments.
RESULTS
Outcome and Follow-Up
Median follow-up time was 11.1 years (interquartile range: 10.2-11.3 years), and follow-up was 100%. End points were CVD and NCD. A total of 62 participants experienced CVD (5.5%). A total of 131 participants experienced NCD (11.5%).
Baseline Characteristics According to Exclusion Status
Excluded participants were characterized by a greater burden of cardiovascular risk factors as determined by BP, body mass index, and diabetes mellitus status (Table  I in the Data Supplement).
Baseline Characteristics of the Population Stratified According to CVD
Participants who experienced CVD were significantly older and more hypertensive. They displayed higher values of systolic BP, diastolic BP, pulse pressure, mean arterial pressure, and body mass index (Table 1) . At baseline, participants who suffered CVD also displayed a significantly higher prevalence of ischemic heart disease, previous AMI, previous ischemic stroke, and HF (Table 1) . Furthermore, plasma concentrations of pro-BNP were significantly higher in participants who suffered CVD, and levels of estimated glomerular filtration rate were lower (Table 1) . LVMD was significantly greater in participants who experienced CVD and so was E/e′, LVMI, left atrium dimension, and deceleration time (Table 1 ). GLS and E/A were significantly lower in participants who suffered CVD. Finally, they also displayed a higher prevalence of reduced systolic function (LVEF <50%) and LV hypertrophy (Table 1) .
Baseline Characteristics of the Population Stratified According to NCD
Participants who experienced NCD were significantly older and more hypertensive (Table 1) . They displayed worse diastolic function as determined by echocardiography; however, LVMD was not significantly different between participants who experienced NCD and participants who did not (Table 1) .
Baseline Characteristics According to Tertiles of LVMD
Patients in the third tertile of LVMD were older, had significantly higher systolic BP, higher diastolic BP, higher pulse pressure, higher mean arterial pressure, higher plasma cholesterol, higher plasma pro-BNP, lower estimated glomerular filtration rate, and a significantly higher prevalence of AMI, hypertension, and left bundle branch block (Table 2) . With regard to echocardiography, patients in the third tertile of LVMD had a significantly higher prevalence of LV hypertrophy, a higher prevalence of LV dilatation, and a higher preva-lence of poor systolic function (LVEF <50%). Patients in the third tertile of LVMD also had significantly higher E/e′, higher LV diastolic diameter indexed to height (LV internal diameter at end diastole/height), higher LVMI, higher left atrium dimension, higher deceleration time, lower absolute GLS, and lower E/e′ 
LVMD and Prediction of CVD
In univariable competing risk regression, LVMD was a significant predictor of CVD (subdistribution hazard ratio [SHR], 1.04; 95% CI, 1.01-1.06; P=0.004; Table 3 ).
In univariable analysis of the population stratified according to tertiles of LVMD, competing risk regression revealed participants in the third tertile of LVMD to display a 3× greater risk of CVD compared with participants in the first tertile (Figure) . In multivariable competing risk regression adjusting for age, sex, hypertension, systolic BP, diabetes mellitus, and smoking, LVMD remained independent predictor of outcome (SHR, 1.06; 95% CI, 1.02-1.10; P=0.001; Table 3 ; model 1).
In a final multivariable competing risk regression model adjusting for age, sex, hypertension, systolic BP, diabetes mellitus, smoking, previous AMI, previous ischemic stroke, prevalent HF, plasma pro-BNP levels, LVEF <50%, left atrium dimension, and GLS, LVMD continued to remain an independent predictor of CVD (Table 3 ; model 2). Results were similar when excluding participants with left bundle branch block or right bundle branch block (LVMD univariable: SHR, 1.04; 95% CI, 1.02-1.07; P=0.003, per 10-ms increase; LVMD model 1: SHR, 1.06; 95% CI, 1.02-1.11; P=0.004, per 10-ms increase; LVMD model 2: SHR, 1.06; 95% CI, 1.03-1.11; P=0.002, per 10-ms increase). In contrast, GLS also predicted CVD in univariable competing risk regression(SHR, 1.08; 95% CI, 1.03-1.15; P=0.032, per 1% decrease). However, GLS was not an independent predictor of outcome in any of the multivariable models (model 1: SHR, 1.02; 95% CI, 0.95-1.10; P=0.54, per 1% decrease; model 2: SHR, 1.00; 95% CI, 0.93-1.07; P=0.95; per 1% decrease). Finally, in a sensitivity analysis, we assessed whether the number of missing LV segments affected our results by adding the number of missing segments as an additional adjusting factor in both models 1 and 2. Our results did not differ in these sensitivity analysis (LVMD model 1 adjusted for missing segments: SHR, 1.06; 95% CI, 1.02-1.10; P=0.003, per 10-ms increase; LVMD model 2 adjusted for missing segments: SHR, 1.06; 95% CI, 1.02-1.10; P=0.005, per 10-ms increase).
LVMD and Prediction of NCD
LVMD was not a significant predictor of NCD in either univariable or multivariable analysis (Table 3) .
Survival According to Exclusion Status
The incidence of CVD was significantly higher in excluded participants when compared with included participants ( Figure I in the Data Supplement). Exclusion status was an univariable predictor of both CVD and NCD (Table II in the Data Supplement). However, after adjustment for age, sex, systolic BP, hypertension, cholesterol, diabetes mellitus, and body mass index, no association between exclusion status and CVD or exclusion status and NCD was present (Table II in the Data Supplement), indicating that the differences in cardiovascular risk factors explained the univariable association with outcome.
Incremental Value of LVMD in Predicting Future CVD in the General Population
We assessed the incremental prognostic value of adding the presence of LV dyssynchrony (defined as LVMD >51ms) to established predictors from the SCORE risk chart (age, sex, systolic BP, smoking status, and cholesterol levels). The presence of LV dyssynchrony provided incremental prognostic information in predicting CVD in addition to predictors from the SCORE risk chart (Table 4 ). In contrast, adding GLS, E/e′, or pro-BNP to the SCORE risk chart predictors did not provide incremental prognostic information in predicting CVD (Table 4) .
We also assessed the incremental value of adding either LV dyssynchrony, GLS, E/e′, or pro-BNP levels to a modified version of the American College of Cardiology/American Heart Association Pooled Cohort Equation (age, sex, hypertension, smoking status, systolic BP, cholesterol levels, and diabetes mellitus) with exclusion of race because all participants in this study were white. Here, results were similar to when investigated parameters were added to the SCORE risk chart, and only the presence of LV dyssynchrony contributed with incremental prognostic information (Table 4) .
Variability Analysis
The intraobserver reproducibility of LVMD was excellent (intraclass correlation coefficient: 0.96; 95% CI, 0.89-0.98; P<0.001) while the interobserver reproducibility When predicting cardiovascular death, noncardiovascular death was treated as a competing risk. When predicting noncardiovascular death, cardiovascular death was treated as a competing risk. Model 1 is adjusted for age, sex, hypertension, systolic blood pressure, diabetes mellitus, and smoking status. Model 2 is adjusted for the same variables as model 1 with the addition of previous acute myocardial infarction, previous ischemic stroke, prevalent heart failure, plasma pro-BNP levels, LVEF <50%, left atrium dimension, and GLS. CVD indicates cardiovascular death; GLS, global longitudinal strain; LVEF, left ventricular ejection fraction; LVMD, left ventricular mechanical dyssynchrony; NCD, noncardiovascular death; pro-BNP, pro-B-type natriuretic peptide; and SHR, subdistribution hazard ratio.
was good (interclass correlation coefficient: 0.80; 95% CI, 0.51-0.92; P<0.001) as determined by intra-and interclass correlation coefficients.
DISCUSSION
In this study, we found that LVMD was an independent predictor of cardiovascular mortality after adjusting for conventional and echocardiographic predictors. Also, adding the presence of LV dyssynchrony, defined as the upper tertile of LVMD values (LVMD >51 ms), to established predictors from the SCORE risk chart and a modified version of the American College of Cardiology/American Heart Association Pooled Cohort Equation contributed with incremental prognostic information in predicting CVD. In contrast, adding either GLS, E/e′, or pro-BNP levels did not contribute with incremental prognostic information in predicting CVD when added to predictors of established risk prediction models. Furthermore, LVMD was not a significant predictor of noncardiovascular mortality, indicating that LVMD specifically predicts risk of CVD. This suggests that adding the presence of LV dyssynchrony determined by echocardiography and assessed as LVMD to established risk prediction models may potentially improve the process of CVD risk stratification in the general population.
Cardiovascular Mortality Risk Stratification in the General Population
Current cardiovascular risk prediction models rely on older and simpler risk factors such as those included in the SCORE risk chart and are characterized by mainly assessing the risk of ischemic cardiovascular disease. 26, 27 A multitude of similar models have been developed, and it was concluded in a recent systematic review by Damen et al 26 that more research into the incremental prognostic information gained by adding new risk factors and parameters to established models is needed. Focusing on only ischemic cardiovascular disease is an issue because many causes of CVD in the general population are of genetic or nonischemic origin. 5 Also, identification of parameters capable of identifying individuals at high risk of SCD, a condition contributing significantly to CVD in the general population, is difficult using noninvasive techniques. 28 For example, we have previously shown that GLS did not predict CVD after multivariable adjustment despite being an independent predictor of HF in the general population. 16 Thus, identifying parameters that are capable of Net reclassification improvement analysis to evaluate incremental prognostic value of adding examined parameters to established predictors of CVD in the general population included in the SCORE risk chart and a modified version of the ACC/AHA Pooled Cohort Equation prediction models (SCORE risk chart predictors: age, sex, smoking status, systolic blood pressure, and cholesterol levels; Modified ACC/AHA Pooled Equation predictors: age, sex, smoking status, systolic blood pressure, cholesterol levels, hypertension, and diabetes mellitus). LV dyssynchrony is defined as LVMD >51 ms. ACC indicates American College of Cardiology; AHA, American Heart Association; CVD, cardiovascular death; GLS, global longitudinal strain; LVMD, left ventricular mechanical dyssynchrony; NRI, net reclassification improvement; pro-BNP, pro-B-type natriuretic peptide; and SCORE, Systematic Coronary Evaluation.
*Statistically significant result.
quantifying risk of both ischemic and nonischemic CVD and adding incremental prognostic information to established risk factors, while also being easily obtainable and noninvasive, therefore presents a challenge. Echocardiography is an easy, cost-effective, and widely used method for assessing cardiac function and may therefore be an optimal candidate for identifying new prognosticators to aid in the process of improving cardiovascular mortality risk stratification in the general population.
LVMD in the General Population
Recently, a study examining physiological determinants and normal values of LVMD in healthy individuals from the general population has been published by Rodríguez-Zanella et al. 29 In this report including 334 white healthy volunteers, mean age was 42 years with range 18 to 79 years, and mean LVMD was 34 ms (SD: 10 ms). In our study, mean age was 56.1 years (SD: 16.2 years) and mean LVMD was 45 ms (SD: 38 ms). Thus, our values of LVMD appear to be higher than the normal values reported by Rodríguez-Zanella et al. 29 However, this may be explained by the higher age of our study sample. Rodríguez-Zanella et al 29 found that increasing age was significantly associated with increasing LVMD after multivariable adjustment. In addition, Rodríguez-Zanella et al 29 demonstrated that GLS and E/e′ were significantly associated with LVMD after multivariable adjustment. This is in accordance with our results because increasing LVMD was associated with decreasing GLS and E/e′ in our study. Thus, because our study sample consisted of unselected individuals from the general population, it is likely that cardiovascular risk factors, such as hypertension and higher age, contributed to the higher values LVMD found in our study.
Prognostic Value of LVMD
LV dyssynchrony has for several years been the target of cardiac resynchronization therapy, indicating that decreasing LV dyssynchrony provides functional benefits with improved systolic and diastolic function as a results. 30 LV dyssynchrony measured as the time difference between peak anteroseptal and peak posterior radial strain is a strong prognosticator of adverse outcomes in HF with reduced ejection fraction even in the absence of electrical dyssynchrony. 31 Also, LVMD has been shown to be an independent predictor of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy and in patients following AMI. 8, 12 LV dyssynchrony, assessed instead as LVMD circumferential strain, has also been shown to be a sensitive marker of the degree of subclinical atherosclerotic burden in coronary and carotid arteries in the multiethnic study of atherosclerosis. 4 This is in accordance with the results of our study because patients in the third tertile of LVMD had significantly higher levels of plasma cholesterol. Considering that a significant cause of SCD in the general population is thought to be clinically silent coronary artery disease, 32 LVMD may be a potential candidate for prediction of SCD in the general population. These considerations point to LVMD being a sensitive integrated marker of both ischemic and nonischemic cardiovascular mortalities, whether it being risk of malignant arrhythmias or risk of future cardiac pump failure, a notion supported by the results of our study.
Although LVMD and other measures of LV dyssynchrony have proven independent prognosticators of adverse outcome in many instances, results with regards to prediction of certain specific outcomes in patient populations with significant cardiac disease have been conflicting. In a recent study of HF patients with preserved ejection fraction, LVMD was a significant predictor of adverse outcome in univariable analysis, but this relationship did not retain statistical significance in multivariable analysis. 33 In a study of first AMI patients treated with late primary percutaneous coronary intervention investigating predictors of adverse LV remodeling, defined as an increase in LV end-systolic volume by 15% at follow-up, LVMD measured at baseline shortly after AMI was significantly associated with the presence of LV remodeling at follow-up. However, LVMD was not an independent prognosticator of LV remodeling when compared with GLS. 34 It is important to realize that LVMD measures intersegmental variation, and therefore, in advanced cardiac disease, the prognostic value of intersegmental variation may not be as important as the degree of global impairment. This notion is supported by results from previous studies. In a study of ischemic heart disease patients with severely reduced systolic function (LVEF <35%), LVMD did not predict a combined end point consisting of ventricular tachyarrhythmias or CVD after intracardiac defibrillator implantation. 35 In a large substudy of the MADIT-CRT trials (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy study) investigating predictors of ventricular tachyarrhythmias in HF with reduced ejection fraction patients, LVMD was not a significant predictor of outcome. This population also had severely compromised systolic function with an average LVEF <30%. 36 Furthermore, in another study, patients with 3 vessel coronary artery disease displayed smaller values of LV dyssynchrony compared with patients with 2 vessel coronary artery disease. 37 This indicates that when the entire ventricle is significantly diseased, LVMD conveys little prognostic value. However, LVMD has been demonstrated as potent predictor of ventricular arrhythmias in patients with preserved systolic function following AMI. 12 Thus, it is possible that LVMD is an accurate predictor of ventricular arrhythmias and cardiovascular mortality in individuals without severely impaired cardiac function. This is supported by the results of our study. We demonstrated LVMD to be an independent predictor of CVD in an unselected sample of the general population after adjustment for multiple clinical and echocardiographic parameters, including adjustment for GLS. Given that LVMD predicted ventricular arrhythmias in AMI patients with preserved systolic function, 12 and that as many as 50% of all CVD may be attributed to SCD, 2, 38 we hypothesize that part of the prognostic value of LVMD in predicting CVD in the general population may be because of its ability to quantify the risk of future SCD.
Implications, Future Considerations, and Limitations
More research into whether LVMD is a good predictor of CVD in the general population is needed. Ideally, LVMD should be evaluated specifically as a predictor of non-SCD and SCD in the general population to determine the prognostic capability of LVMD in both regards. In this study, we were not able to discern CVDs into either SCD or non-SCD. Also, research into whether LVMD is capable of providing prognostic information in patients with genetic abnormalities predisposing to SCD is recommended, especially with regards to predicting future ventricular arrhythmias. One study found that the timing of mechanical contraction was longer in the subendocardium than the midmyocardium in symptomatic long-QT patients but not in healthy individuals, indicating transmural LV dyssynchrony. 39 In this study, LVMD was significantly greater in symptomatic long-QT patients compared with patients not displaying arrhythmias. LVMD may, therefore, also convey prognostic information with regard to ventricular arrhythmias in genetic conditions predisposing to SCD.
Several limitations of the present report need to be mentioned. These include lack of data designating specific CVD causes and the small number of CVD events. Because of this relatively small number of events, the extent of our multivariable adjustment and analysis was limited. In this study, we assessed cause of death through International Classification of Diseases, Tenth Revision codes, and it was not possible to accurately ascertain how great a proportion of CVDs were attributable to SCD and malignant ventricular arrhythmias. Because of this, it is difficult to ascertain whether the significance of LVMD as a predictor of CVD in this study was because of proficiency in predicting either SCD, non-SCD, or both. Validation of our findings in another general population sample with greater attention to the cause of CVD, whether it being SCD or non-SCD, will elucidate whether LVMD is a useful independent prognosticator of CVD in the general population. Because the echocardiograms used in this study were recorded in a busy clinical setting, we were not able to calculate LVMD from all 3 apical views in all patients. However, currently no consensus exists on whether all 3 apical projections should be included or whether 2 apical views are sufficient. In MADIT-CRT, the largest trial to date assessing LVMD, the investigators assessed LVMD from 12 segments from 2 apical views. 33 However, other studies have tried to include all 3 apical projections when assessing LVMD. 40, 41 More research is needed before it can be determined whether LVMD should be added to risk stratification models. However, as has been concluded by Damen et al 26 in a recent systematic review, it is important to evaluate the incremental prognostic value of adding new parameters to already established prediction models. Measures based on imaging such as LVMD are not meant to replace established and highly feasible risk models, such as SCORE. They are meant to refine and improve what we already know. In a position statement from the European Society of Cardiology from 2014, it is stated that better identification of individuals at risk for atherosclerosis and sudden death in the general population is needed. 42 However, it is also stated that contemporary cardiovascular medicine already uses aspects of personalized medicine through SCORE and other risk prediction models, 42 and thus the focus should be on improving these models with new technologies and modalities instead of disregarding established methods. 26, 42 Hence, our study provides precedence for more research into how LVMD determined by echocardiography may be used to refine cardiovascular risk assessment in the general population. Finally, our study population consisted mainly of whites, and our results are, therefore, not directly applicable to all ethnicities.
Conclusions
LV mechanical dyssynchrony adds incremental prognostic information in addition to established risk factors in prediction of CVD in individuals from the general population without atrial fibrillation and significant valvular disease.
